SCHEMBL7293157

SCHEMBL7293157

CC(=O)SCC(Cc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
CYP2C19 P33261 1/20 0.69
ABCC3 O15438 1/20 0.69
NR1I2 O75469 1/20 0.69
ABCB11 O95342 1/20 0.69
NR3C1 P04150 1/20 0.69
RARG P13631 1/20 0.69
CNR1 P21554 1/20 0.69
OPRK1 P41145 1/20 0.69
NR1H2 P55055 1/20 0.69
PPARA Q07869 1/20 0.69
NR1H3 Q13133 1/20 0.69
NR1I3 Q14994 1/20 0.69
ALDH1A1 P00352 4/20 0.51
HRH4 Q9H3N8 1/20 0.51
MME P08473 2/20 0.46
SLC15A1 P46059 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141032 0.88 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4177084 0.87 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4804596 0.86 CYP1A2 (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7277529 0.84 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4611137 0.83 CYP1A2 (0.59) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6154521 0.83 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL838962 0.83 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL838961 0.83 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Ecadotril SCHEMBL48974 0.82 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
Dexecadotril SCHEMBL1649041 0.82 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712417-A Inhibitors of retroviral proteases ABBOTT LABORATORIES (US) 1998-01-27 US disclosed
EP-0456185-B1 Renin inhibitors ABBOTT LAB (US) 1995-05-31 EP disclosed
US-5332742-A Ocular hypotensive ABBOTT LABORATORIES (US) 1994-07-26 US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 US disclosed
US-5258362-A Enzyme inhibitors, amides with oxetane ring ABBOTT LABORATORIES (US) 1993-11-02 US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 EP disclosed
US-5063208-A Cardiovascular disorders, vision defects ABBOTT LABORATORIES (US) 1991-11-05 US disclosed
EP-0410260-A2 Peptidyl aminodiol renin inhibitors ABBOTT LABORATORIES (US) 1991-01-30 EP disclosed
WO-1989010751-A1 FUNCTIONALIZED PEPTIDYL AMINODIOLS AND -TRIOLS ABBOTT LABORATORIES (US) 1989-11-16 WO disclosed
EP-0341602-A2 Renin-inhibiting functionalized peptidyl aminodiols and - triols ABBOTT LABORATORIES (US) 1989-11-15 EP disclosed